Moderna Inc said on Wednesday smaller volume agreements for its experimental coronavirus vaccine candidate have been executed between $32 and $37 per dose.
"We will be responsible on price well below value during the pandemic," Chief Executive Officer Stéphane Bancel said on a conference call, adding that larger volume agreements under discussion will be at a lower price.